Cooperation of hTERT, SV40 T antigen and oncogenic Ras in tumorigenesis: A cell transplantation model using bovine adrenocortical cells

Neoplasia

Volumn 4, Issue 6, 2002, Pages 493-500

  Thomas, Michael ^a,b   Suwa, Tetsuya ^a,c   Yang, Lianqing ^a   Zhao, Lifang ^a   Hawks, Christina L ^c   Hornsby, Peter J ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b INSERM   (France)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Adrenal cortex; Cell transplantation; Oncogenic Ras; SV40 T antigen; Telomerase

Indexed keywords

RAS PROTEIN; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; VIRUS T ANTIGEN; DNA BINDING PROTEIN; HRAS PROTEIN, HUMAN; PROTEIN P21; TERT PROTEIN, HUMAN; TERT PROTEIN, MOUSE;

ADRENAL CORTEX CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL TRANSPLANTATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; KIDNEY CAPSULE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SCID MOUSE; SIMIAN VIRUS 40; ADRENAL CORTEX; ANIMAL; BIOLOGICAL MODEL; CATTLE; CELL CULTURE; CELL TRANSFORMATION; COMPARATIVE STUDY; CYTOLOGY; ENZYME IMMUNOASSAY; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; KIDNEY TUMOR; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION; VIRUS CELL TRANSFORMATION; WESTERN BLOTTING;

ADRENAL CORTEX; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BLOTTING, WESTERN; CATTLE; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CELL TRANSPLANTATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MALE; MICE; MICE, SCID; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS P21(RAS); TELOMERASE; TRANSFECTION;

EID: 0036858627     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900262     Document Type: Article

References (43)

1. Greider CW (1998). Telomeres and senescence: The history, the experiment, the future. Curr Biol 8, R178-81.
2. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichsteiner S, and Wright WE (1998). Extension of life span by introduction of telomerase into normal human cells. Science 279, 349-52.
3. Wright WE, and Shay JW (2001). Cellular senescence as a tumor-protection mechanism: The essential role of counting, Curr Opin Genet Dev 11, 98-103.
4. Lanza RP, Cibelli JB, Blackwell C, Cristofalo VJ, Francis MK, Baerlocher GM, Mak J, Schertzer M, Chavez EA, Sawyer N, Lansdorp PM, and West MD (2000). Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science 288, 665-69.
5. Thomas M, Yang L, and Hornsby PJ (2000). Formation of normal functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase. Nat Biotechnol 18, 39-42.
6. Wright WE, and Shay JW (2000). Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology. Nat Med 6, 849-51.
7. Macieira-Coelho A (1988). Biology of Normal Proliferating Cells in Vitro. Relevance for in Vivo Aging. Karger, Basel. p. 17.
8. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, and Weinberg RA (1999). Creation of human tumour cells with defined genetic elements. Nature 400, 464-68.
9. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, and Weinberg RA (2001). Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15, 50-65.
10. Zimonjic D, Brooks MW, Popescu N, Weinberg RA, and Hahn WC (2001). Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res 61, 8838-44.
11. Rich JN, Guo C, McLendon RE, Bigner DD, Wang XF, and Counter CM (2001). A genetically tractable model of human glioma formation. Cancer Res 61, 3556-60.
12. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS, and Pieper RO (2001). Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 61, 4956-60.
13. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, and Weinberg RA (2002). Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22, 2111-23.
14. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, and Chiu CP (1999). Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21, 111-14.
15. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, and Shay JW (1999). Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21, 115-18.
16. Shay JW, and Wright WE (2000). The use of telomerized cells for tissue engineering. Nat Biotechnol 18, 22-23.
17. Yang J, Nagavarapu U, Relloma K, Sjaastad MD, Moss WC, Passaniti A, and Herron GS (2001). Telomerized human microvasculature is functional in vivo. Nat Biotechnol 19, 219-24.
18. Thomas M, Northrup SR, and Hornsby PJ (1997). Adrenocortical tissue formed by transplantation of normal clones of bovine adrenocortical cells in scid mice replaces the essential functions of the animals' adrenal glands. Nat Med 3, 978-83.
19. Funk WD, Wang CK, Shelton DN, Harley CB, Pagon GD, and Hoeffler WK (2000). Telomerase expression restores dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model. Exp Cell Res 258, 270-78.
20. Farwell DG, Shera KA, Koop JI, Bonnet GA, Matthews CP, Reuther GW, Coltrera MD, McDougall JK, and Klingelhutz AJ (2000). Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am J Pathol 156, 1537-47.
21. Hornsby PJ, and McAllister JM (1991). Culturing steroidogenic cells. Methods in Enzymology, Vol. 206. In: MR Waterman, and EF Johnson (Eds) Academic Press, San Diego. pp. 371-80.
22. Miller AD, and Chen F (1996). Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol 70, 5564-71.
23. Suwa T, Yang L, and Hornsby PJ (2001). Telomerase activity in primary cultures of normal adrenocortical cells. J Endocrinol 170, 677-84.
24. Kim SH, Kaminker P, and Campisi J (1999). TIN2, a new regulator of telomere length in human cells. Nat Genet 23, 405-12.
25. Jat PS, Cepko CL, Mulligan RC, and Sharp PA (1986). Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens. Mol Cell Biol 6, 1204-17.
26. Harlow E, Crawford LV, Pim DC, and Williamson NM (1981). Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol 39, 861-69.
27. Thomas M, and Hornsby PJ (1999). Transplantation of primary bovine adrenocortical cells into scid mice. Mol Cell Endocrinol 153, 125-36.
28. Forough R, Xi Z, MacPhee M, Friedman S, Engleka KA, Sayers T, Wiltrout RH, and Maciag T (1993). Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1. J Biol Chem 268, 2960-68.
29. Didenko VV, Tunstead JR, and Hornsby PJ (1998). Biotin-labeled hairpin oligonucleotides. Probes to detect double-strand breaks in DNA in apoptotic cells. Am J Pathol 152, 897-902.
30. Hornsby PJ, Cheng CY, Lala DS, Maghsoudlou SS, Raju SG, and Yang L (1992). Changes in gene expression during senescence of adrenocortical cells in culture. J Steroid Biochem Mol Biol 43, 951-60.
31. Butel JS, and Lednicky JA (1999). Cell and molecular biology of simian virus 40; implications for human infections and disease. J Natl Cancer Inst 91, 119-34.
32. Pipas JM, and Levine AJ (2001). Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol 11, 23-30.
33. Ali SH, and DeCaprio JA (2001). Cellular transformation by SV40 large T antigen: Interaction with host proteins. Semin Cancer Biol 11, 15-23.
34. Huang S, and lngber DE (1999). The structural and mechanical complexity of cell-growth control. Nat Cell Biol 1, E131-38.
35. Naik P, Karrim J, and Hanahan D (1996). The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev 10, 2105-16.
36. Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML, and Graessmann A (1998). SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors. Oncogene 16, 2103-14.
37. Fu W, Begley JG, Killen MW, and Mattson MP (1999). Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem 274, 7264-71.
38. Zhu H, Fu W, and Mattson MP (2000). The catalytic subunit of telomerase protects neurons against amyloid β-peptide-induced apoptosis. J Neurochem 75, 117-24.
39. Oh H, Taffet GE, Youker KA, Entman ML, Overbeek PA, Michael LH, and Schneider MD (2001). Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci USA 98, 10308-13.
40. Kriegier M, Perez CF, Hardy C, and Botchan M (1984). Transformation mediated by the SV40 T antigens: Separation of the overlapping SV40 early genes with a retroviral vector. Cell 38, 483-91.
41. Serrano M, Lin AW, McCurrach ME, Beach D, and Lowe SW (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16 INK4A. Cell 88, 593-602.
42. Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, Yu ZX, Ferrans VJ, Howard BH, and Finkel T (1999). Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274, 7936-40.
43. Weinberg RA (1998). Telomeres. Bumps on the road to immortality. Nature 396, 23-24.